ArticleBMC biotechnology2025
Magnetron sputtering to enhance bone integration of tantalum-coated titanium implants: an in vitro and in vivo analysis.
Article in BMC biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Ti6Al4V (TC4) widely used in bone implants, has good mechanical properties but unremarkable bone-forming capacity. Tantalum (Ta) features excellent biocompatibility and suitability for osteogenesis, albeit with a significantly higher elastic-modulus. In this study, we combined the strengths of both materials to optimize implant materials. Magnetron sputtering was applied to deposit a Ta coating onto the TC4 surface (Ta-C-TC4). Surface characteristics were assessed via scanning electron microscope (SEM). Cell adhesion was assessed using SEM and cytoskeletal staining, while live/dead staining was used to evaluate cell viability and biocompatibility on the material surfaces. For proliferation analysis, fluorescence transfection and CCK-8 assay were utilized, while quantification of substance and qRT-PCR were employed to assess the osteogenic differentiation. In vivo, fluorescence labelling, VG, and Goldner staining were employed to evaluate bone integration. A 550 nm-thick Ta coating was successfully achieved on Ta-C-TC4, and its elements and morphology closely resembled Ta. Cells exhibited more pronounced proliferation and differentiation on Ta and Ta-C-TC4. More extensive encasement of new bone was observed around Ta and Ta-C-TC4. Ta-C-TC4 exhibits biocompatibility on par with Ta and demonstrates superior bone integration compared to TC4. Magnetron sputtering represents a promising strategy to harness the mechanical attributes of TC4 with the biological characteristics of Ta, thereby holding potential for the advancement of bone implant.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.